• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

儿童肥胖与随后发生 1 型糖尿病的关联:系统评价和荟萃分析。

Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis.

机构信息

Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.

出版信息

Diabet Med. 2011 Jan;28(1):10-8. doi: 10.1111/j.1464-5491.2010.03160.x.

DOI:10.1111/j.1464-5491.2010.03160.x
PMID:21166841
Abstract

AIMS

To review and synthesize the published evidence on the possible association between childhood obesity and the subsequent risk of Type 1 diabetes.

METHODS

The PubMed database was systematically searched for studies using childhood obesity, BMI or %weight-for-height as the exposure variable and subsequent Type 1 diabetes as the outcome. Studies were only included if assessment of obesity preceded the diagnosis of Type 1 diabetes.

RESULTS

Eight case-control studies and one cohort study were included, comprising a total of 2658 cases. Of these nine studies, seven reported a significant association between childhood obesity, BMI or %weight-for-height and increased risk for Type 1 diabetes. Meta-analysis of the four studies that reported childhood obesity as a categorical exposure produced a pooled odds ratio of 2.03 (95% CI 1.46-2.80) for subsequent Type 1 diabetes; however, in those studies, age at obesity assessment varied from age 1 to 12 years. A dose-response relationship was supported by a continuous association between childhood BMI and subsequent Type 1 diabetes in a meta-analysis of five studies (pooled odds ratio 1.25 (95%CI 1.04-1.51) per 1 sd higher BMI).

CONCLUSION

There is overall evidence for an association between childhood obesity, or higher BMI, and increased risk of subsequent Type 1 diabetes. Several theories have been proposed for a causal relationship. Reduction in Type 1 diabetes should be considered as a potential additional benefit of preventing childhood obesity.

摘要

目的

综述并综合已发表的证据,探讨儿童肥胖与随后发生 1 型糖尿病风险之间的可能关联。

方法

系统检索 PubMed 数据库中使用儿童肥胖、BMI 或体重身高比作为暴露变量,以及随后发生 1 型糖尿病作为结局的研究。仅纳入在诊断 1 型糖尿病之前评估肥胖的研究。

结果

纳入了 8 项病例对照研究和 1 项队列研究,共包含 2658 例病例。这 9 项研究中有 7 项报道了儿童肥胖、BMI 或体重身高比与 1 型糖尿病风险增加之间存在显著关联。对报道儿童肥胖为分类暴露的 4 项研究进行荟萃分析,得出随后发生 1 型糖尿病的合并优势比为 2.03(95%CI 1.46-2.80);然而,在这些研究中,肥胖评估的年龄从 1 岁到 12 岁不等。对 5 项研究进行荟萃分析显示,儿童 BMI 与随后发生 1 型糖尿病之间存在连续关联,支持了剂量-反应关系(每增加 1 个标准差 BMI,合并优势比为 1.25(95%CI 1.04-1.51))。

结论

总体而言,有证据表明儿童肥胖或更高的 BMI 与随后发生 1 型糖尿病的风险增加有关。已经提出了几种因果关系的理论。在预防儿童肥胖的潜在额外益处中,应考虑降低 1 型糖尿病的风险。

相似文献

1
Association between childhood obesity and subsequent Type 1 diabetes: a systematic review and meta-analysis.儿童肥胖与随后发生 1 型糖尿病的关联:系统评价和荟萃分析。
Diabet Med. 2011 Jan;28(1):10-8. doi: 10.1111/j.1464-5491.2010.03160.x.
2
Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.静脉注射硫酸镁和索他洛尔预防冠状动脉搭桥术后房颤:系统评价与经济学评估
Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. doi: 10.3310/hta12280.
3
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.系统性药理学治疗慢性斑块状银屑病:网络荟萃分析。
Cochrane Database Syst Rev. 2021 Apr 19;4(4):CD011535. doi: 10.1002/14651858.CD011535.pub4.
4
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review.在初级保健中使用药物治疗肥胖患者的临床效果和成本效益如何?系统评价。
Health Technol Assess. 2012;16(5):iii-xiv, 1-195. doi: 10.3310/hta16050.
5
Dietary interventions for recurrent abdominal pain in childhood.儿童复发性腹痛的饮食干预措施
Cochrane Database Syst Rev. 2017 Mar 23;3(3):CD010972. doi: 10.1002/14651858.CD010972.pub2.
6
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状Meta分析。
Cochrane Database Syst Rev. 2020 Jan 9;1(1):CD011535. doi: 10.1002/14651858.CD011535.pub3.
7
Gestational weight gain below instead of within the guidelines per class of maternal obesity: a systematic review and meta-analysis of obstetrical and neonatal outcomes.按孕妇肥胖类别划分,孕期体重增加未达而非处于指南范围:产科和新生儿结局的系统评价与荟萃分析
Am J Obstet Gynecol MFM. 2022 Sep;4(5):100682. doi: 10.1016/j.ajogmf.2022.100682. Epub 2022 Jun 18.
8
Selenium for preventing cancer.硒预防癌症。
Cochrane Database Syst Rev. 2018 Jan 29;1(1):CD005195. doi: 10.1002/14651858.CD005195.pub4.
9
Systemic pharmacological treatments for chronic plaque psoriasis: a network meta-analysis.慢性斑块状银屑病的全身药理学治疗:一项网状荟萃分析。
Cochrane Database Syst Rev. 2017 Dec 22;12(12):CD011535. doi: 10.1002/14651858.CD011535.pub2.
10
Cumulative methotrexate dose is not associated with liver fibrosis in patients with a history of moderate-to-severe psoriasis.累积甲氨蝶呤剂量与有中重度银屑病病史患者的肝纤维化无关。
Br J Dermatol. 2024 Jul 16;191(2):275-283. doi: 10.1093/bjd/ljae069.

引用本文的文献

1
Obesity and the Gut-Brain Axis in Type 1 Diabetes Mellitus: Terra Incognita?1型糖尿病中的肥胖与肠脑轴:未知领域?
Curr Obes Rep. 2025 Jul 25;14(1):61. doi: 10.1007/s13679-025-00654-8.
2
Gestational diabetes and parental type 2 diabetes as risk indicators for type 1 diabetes in offspring: a systematic review and meta-analysis.妊娠期糖尿病和父母2型糖尿病作为后代1型糖尿病的风险指标:一项系统评价和荟萃分析。
EClinicalMedicine. 2025 Jul 4;85:103321. doi: 10.1016/j.eclinm.2025.103321. eCollection 2025 Jul.
3
Immune cell-adipose tissue crosstalk in metabolic diseases with a focus on type 1 diabetes.
免疫细胞与脂肪组织在代谢性疾病中的相互作用,重点关注1型糖尿病
Diabetologia. 2025 Jun 4. doi: 10.1007/s00125-025-06437-z.
4
Stable heritability of type 1 diabetes in a Swedish Nationwide Cohort Study.瑞典全国队列研究中1型糖尿病的稳定遗传性
Nat Commun. 2025 Jun 17;16(1):5327. doi: 10.1038/s41467-025-60813-2.
5
Large-scale analysis highlights obesity as a risk factor for chronic, non-communicable inflammatory diseases.大规模分析突出了肥胖是慢性非传染性炎症性疾病的一个风险因素。
Front Endocrinol (Lausanne). 2025 Feb 3;16:1516433. doi: 10.3389/fendo.2025.1516433. eCollection 2025.
6
Glucagon-like peptide-1 receptor agonists and type 1 diabetes: a potential game changer?胰高血糖素样肽-1受体激动剂与1型糖尿病:会是一个潜在的游戏规则改变者吗?
Front Endocrinol (Lausanne). 2025 Jan 21;15:1520313. doi: 10.3389/fendo.2024.1520313. eCollection 2024.
7
Interaction of B0AT1 Deficiency and Diet on Metabolic Function and Diabetes Incidence in Male Nonobese Diabetic Mice.B0AT1缺乏与饮食对雄性非肥胖糖尿病小鼠代谢功能和糖尿病发病率的相互作用
Endocrinology. 2025 Feb 5;166(3). doi: 10.1210/endocr/bqaf016.
8
Population-based prevalence of self-reported pediatric diabetes and screening for undiagnosed type 2 diabetes in Chinese children in years 2017-2019, a cross-sectional study.2017 - 2019年中国儿童自我报告的儿科糖尿病患病率及未诊断的2型糖尿病筛查:一项横断面研究
Lancet Reg Health West Pac. 2024 Sep 18;52:101206. doi: 10.1016/j.lanwpc.2024.101206. eCollection 2024 Nov.
9
Family History of Diabetes and Clinical Characteristics in Children at Diagnosis of Type 1 Diabetes-A Swedish Population-Based Study.1 型糖尿病患儿发病时的糖尿病家族史和临床特征:一项瑞典基于人群的研究。
Diabetes Care. 2024 Nov 1;47(11):2012-2016. doi: 10.2337/dc24-0534.
10
Racial/Ethnic Differences in the Age-Varying Association Between Adherence to 8-5-2-1-0 Guidelines in Adolescents with High BMI.高BMI青少年遵循8-5-2-1-0指南的年龄差异与种族/民族差异
J Racial Ethn Health Disparities. 2024 Sep 3. doi: 10.1007/s40615-024-02102-0.